TRMT2B and central nervous system cancer: Moreover, we observed protein expression of MRM1, MRM3, TRMT2B, and NSUN4 to be significantly different between low- and high-grade gliomas, whereas other regulators could not be obtained due to lack of data (Supplementary Figures S1B–D).